Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$202.68M-20.1%-$196.54M+24.6%-$192.33M+25.7%-$183.1M+29.4%-$168.73M+38.4%
$77.06M+72.1%$66.82M+68.4%$58.11M+53.7%$50.3M+42.0%$44.78M+31.9%
-$119.51M-5.3%-$115.68M-1.6%-$109.13M+12.3%-$107.72M+16.1%-$113.49M+19.2%
$19.59M+33.0%$19.92M+54.4%$18.33M+57.1%$16.09M+53.3%$14.73M+66.8%
$219.5M+179%
-$45.9M-187%-$36.85M-226%$4.77M+128%-$26.02M-156%$52.67M+185%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Rhythm Pharmaceuticals, Inc. generate?
Rhythm Pharmaceuticals, Inc. (RYTM) generated -$119.5M in operating cash flow over the trailing twelve months.
Where does Rhythm Pharmaceuticals, Inc.'s cash flow data come from?
Every line is extracted from Rhythm Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.